Morgan Stanley’s Counterpath Corp CPAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,950
| Closed | -$6K | – | 6920 |
|
|
2020
Q1 | $6K | Buy |
2,950
+2,900
| +5,800% | +$6.54K | ﹤0.01% | 6180 |
|
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 6987 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 6965 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 6941 |
|
|
2019
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 6925 |
|
|
2018
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 6971 |
|
|
2018
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 7004 |
|
|
2018
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 6954 |
|
|
2018
Q1 | $0 | Sell |
50
-29,412
| -100% | -$115K | ﹤0.01% | 6896 |
|
|
2017
Q4 | $95K | Buy |
29,462
+29,412
| +58,824% | +$75.7K | ﹤0.01% | 5650 |
|
|
2017
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 6800 |
|
|
2017
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 6819 |
|
|
2017
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 6755 |
|
|
2016
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 6710 |
|
|
2016
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 6736 |
|
|
2016
Q2 | $0 | Sell |
50
-8
| -14% | -$18 | ﹤0.01% | 6962 |
|
|
2016
Q1 | $0 | Hold |
58
| – | – | ﹤0.01% | 7009 |
|
|
2015
Q4 | $0 | Buy |
58
+8
| +16% | +$27 | ﹤0.01% | 7042 |
|
|
2015
Q3 | $0 | Sell |
50
-7
| -12% | -$33 | ﹤0.01% | 6917 |
|
|
2015
Q2 | $0 | Hold |
57
| – | – | ﹤0.01% | 6916 |
|
|
2015
Q1 | $0 | Hold |
57
| – | – | ﹤0.01% | 6819 |
|
|
2014
Q4 | $0 | Hold |
57
| – | – | ﹤0.01% | 6828 |
|
|
2014
Q3 | $0 | Hold |
57
| – | – | ﹤0.01% | 6792 |
|
|
2014
Q2 | $1K | Hold |
57
| – | – | ﹤0.01% | 6473 |
|
|
2014
Q1 | $1K | Buy |
57
+7
| +14% | +$84 | ﹤0.01% | 6431 |
|
|
2013
Q4 | $1K | Buy |
+50
| New | +$655 | ﹤0.01% | 6330 |
|
Other funds holding CPAH
BCM
VF
Morgan Stanley's CPAH Position: Q2 2020 in Review
Morgan Stanley sold out of Counterpath Corp (CPAH) in Q2 2020, closing a stake of 2,950 shares — an estimated $6K sold.
Morgan Stanley first reported a position in CPAH in Q4 2013 and held it in 26 quarters. The position peaked at $95K in Q4 2017. 9 funds tracked by Wall St. Rank hold CPAH as of Q2 2020.
- Morgan Stanley reported no remaining Counterpath Corp position as of Q2 2020 after selling out during the quarter.
- Morgan Stanley sold 2,950 Counterpath Corp shares in Q2 2020, an estimated $6K.
- Morgan Stanley first reported a position in Counterpath Corp in Q4 2013 and held it in 26 quarters.
- Morgan Stanley's Counterpath Corp position peaked at $95K in Q4 2017.
- 9 funds tracked by Wall St. Rank held Counterpath Corp as of Q2 2020.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.